Bristol Startup Wins Global MedTech Innovation World Cup with Rapid Bacterial Diagnosis Technology

FluoretiQ Limited, a University of Bristol spinout developing rapid point-of-care bacterial diagnostics, has won first place at the MedTech Innovation World Cup 2026 in Hong Kong — one of the world's most established open innovation competitions for health technologies. The company beat more than 210 startups, scaleups, and SMEs from across the globe to take the top spot, with technology that could revolutionize how infections are diagnosed and treated.

The company's proprietary platforms address one of healthcare's most urgent challenges: antimicrobial resistance (AMR). Currently, diagnosing bacterial infections typically requires sending samples to a laboratory, where cultures must be grown over 24 to 72 hours before the causative pathogen can be identified. During this waiting period, doctors often prescribe broad-spectrum antibiotics as a precaution — a practice that contributes to the growing crisis of antibiotic-resistant bacteria.

“The company beat more than 210 startups, scaleups, and SMEs from across the globe to take the top spot, with technology that could revolutionize how infections are diagnosed and treated.”

FluoretiQ's technology reduces this diagnostic window from days to minutes, enabling healthcare providers to identify specific pathogens at the point of care and prescribe targeted antibiotics immediately. This precision approach could dramatically reduce unnecessary antibiotic prescriptions, slowing the development of resistant bacteria while ensuring patients receive the right treatment faster.

The company's first commercial product, VERI-5 Vet, is designed specifically for veterinary practice and identifies the most common canine and feline urinary tract pathogens directly from urine samples, achieving 91% sensitivity and 92% specificity. The technology is now being adapted for human healthcare applications, where the potential impact is enormous.

The Grand Finale of the MedTech Innovation World Cup took place on March 5, 2026, at the Wearable Technologies Conference in Hong Kong. FluoretiQ's pitch impressed an international expert judging panel including representatives from Santander Bank, Hong Kong Science and Technology Parks Corporation, EY, The Chinese University of Hong Kong, The University of Cambridge, and STMicroelectronics.

Founded in 2017, FluoretiQ represents the kind of university-to-market innovation pipeline that is increasingly crucial for addressing global health challenges. The World Health Organization has identified AMR as one of the top 10 global public health threats, estimating that drug-resistant infections could cause 10 million deaths annually by 2050 without decisive action.